Clinical Trial Update: Odiparcil For The Prevention Of Venous Thromboembolism [Phase 2]

View source ↗

Summary

Phase 2 trial of Odiparcil for the prevention of venous thromboembolism has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Odiparcil (odiparcil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Deep Vein Thrombosis, Fibrillation, Atrial | Phase 2 | Status: COMPLETED | Results posted: 2017-05-02